DMAC Stock Analysis: Buy, Sell, or Hold?
DMAC - DiaMedica Therapeutics Inc. Common Stock
$8.04
-0.43 (-5.08%)
▼
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Mar 16, 2026
Smart Money Accumulation
DMAC is down 5.5% this week, but smart money is accumulating calls. Top strike: $10 2026-04-17 with 486 OI. Call ratio: 100% View Scanner →
Strength: 7.8/10
Get Alerted When DMAC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: DMAC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: DMAC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: DMAC is currently trading at $8.04, which is considered slightly low relative to its 30-day fair value range of $7.95 to $8.57.
Technical Outlook: Technically, DMAC is in a uptrend. Immediate support is located at $7.17, while resistance sits at $9.00. Short-term momentum is weak, with the stock down 5.1% recently.
Market Sentiment: DMAC has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $15.50 (+92.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, DMAC is in a uptrend. Immediate support is located at $7.17, while resistance sits at $9.00. Short-term momentum is weak, with the stock down 5.1% recently.
Market Sentiment: DMAC has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $15.50 (+92.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$7.95 -
$8.57
Company Quality Score
51/100
(HOLD)
Options IV Signal
36th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
56.2%
Protect Your Profits
Holding DMAC? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 36th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.1%)
- BULLISH: Trading 92.8% below Wall St target ($15.50)
- CAUTION: 5-day price weakness (-5.5%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$7.95 -
$8.57
Current vs Fair Value
SLIGHTLY LOW
Expected Move (7 Days)
±$1.85
(23.0%)
Support & Resistance Levels
Support Level
$7.17
Resistance Level
$9.00
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-10.63
Wall Street Target
$15.50
(+92.8%)
Last updated: January 31, 2026 11:10 PM ET
Data refreshes hourly during market hours. Next update: 12:10 AM
Data refreshes hourly during market hours. Next update: 12:10 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DMAC showing a specific setup today?
Insider Activity (6 Months)
9
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Jan Stahlberg
BUY
50772 shares
2025-08-27
Jan Stahlberg
BUY
59648 shares
2025-08-26
Jan Stahlberg
BUY
338265 shares
2025-08-25
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$404 | 63 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$56 | 59 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$210 | 57 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 56 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$85 | 55 HOLD |
Advanced DMAC Option Strategies
Professional options setups generated by AI based on today's DMAC price and gamma walls.
